Dietary Derived Propionate Regulates Pathogenic Fibroblast Function and Ameliorates Experimental Arthritis and Inflammatory Tissue Priming.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
13 May 2021
Historique:
received: 30 03 2021
revised: 04 05 2021
accepted: 10 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 23 7 2021
Statut: epublish

Résumé

Short-chain fatty acids are gut-bacteria-derived metabolites that execute important regulatory functions on adaptive immune responses, yet their influence on inflammation driven by innate immunity remains understudied. Here, we show that propionate treatment in drinking water or upon local application into the joint reduced experimental arthritis and lowered inflammatory tissue priming mediated by synovial fibroblasts. On a cellular level, incubation of synovial fibroblasts with propionate or a physiological mixture of short-chain fatty acids interfered with production of inflammatory mediators and migration and induced immune-regulatory fibroblast senescence. Our study suggests that propionate mediates its alleviating effect on arthritis by direct abrogation of local arthritogenic fibroblast function.

Identifiants

pubmed: 34068191
pii: nu13051643
doi: 10.3390/nu13051643
pmc: PMC8152983
pii:
doi:

Substances chimiques

Propionates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Research Foundation (DFG)
ID : DFG - FG 2886 "PANDORA" - projects No. 01 and No.08
Organisme : German Research Foundation (DFG)
ID : CRC1181 - Project no. B07

Références

Nat Commun. 2018 Jan 4;9(1):55
pubmed: 29302038
Nat Rev Immunol. 2007 Jun;7(6):429-42
pubmed: 17525752
Immunity. 2021 May 11;54(5):1002-1021.e10
pubmed: 33761330
J Periodontol. 1999 Dec;70(12):1435-42
pubmed: 10632518
Arthritis Res Ther. 2016 Nov 18;18(1):270
pubmed: 27863512
Nat Rev Rheumatol. 2020 Jun;16(6):316-333
pubmed: 32393826
Nutrients. 2020 Oct 20;12(10):
pubmed: 33092271
Arthritis Res Ther. 2017 Feb 10;19(1):35
pubmed: 28187781
Minerva Stomatol. 1993 Nov-Dec;42(11-12):481-5
pubmed: 8164622
Clin Transl Immunology. 2016 Apr 22;5(4):e73
pubmed: 27195116
Eplasty. 2019 Mar 1;19:e4
pubmed: 30858902
PLoS One. 2011;6(6):e21205
pubmed: 21698257
Mucosal Immunol. 2018 Sep;11(5):1466-1476
pubmed: 29988118
Methods Mol Med. 2007;136:243-53
pubmed: 17983153
Nat Commun. 2018 Feb 23;9(1):789
pubmed: 29476097
Nat Rev Rheumatol. 2020 Aug;16(8):415-433
pubmed: 32661321
Immunity. 2017 Feb 21;46(2):220-232
pubmed: 28228280
Cell. 2020 Mar 19;180(6):1067-1080.e16
pubmed: 32160527
J Clin Med. 2017 Jun 09;6(6):
pubmed: 28598360
Exp Mol Med. 2019 Dec 11;51(12):1-6
pubmed: 31827063
Nutrients. 2019 Oct 07;11(10):
pubmed: 31591345
J Nutr Biochem. 2011 Sep;22(9):849-55
pubmed: 21167700
Nat Rev Rheumatol. 2013 Jan;9(1):24-33
pubmed: 23147896
Nat Med. 2014 Feb;20(2):159-66
pubmed: 24390308
Nature. 2020 Jun;582(7811):259-264
pubmed: 32499639
Rheumatology (Oxford). 2017 Jun 1;56(6):863-864
pubmed: 27498350
J Autoimmun. 2021 Jan;116:102564
pubmed: 33203617
FASEB J. 2020 Feb;34(2):2198-2212
pubmed: 31907988
J Rheumatol. 2008 Aug;35(8):1477-14797
pubmed: 18671318
Nature. 2009 Oct 29;461(7268):1282-6
pubmed: 19865172
Nat Commun. 2020 Feb 6;11(1):745
pubmed: 32029712
Nat Rev Immunol. 2021 Apr 28;:
pubmed: 33911232
Immunity. 2018 Dec 18;49(6):1116-1131.e7
pubmed: 30446387
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
Ann Rheum Dis. 2017 Dec;76(12):2105-2112
pubmed: 28847766
Immunity. 2015 Nov 17;43(5):998-1010
pubmed: 26522986
J Autoimmun. 2017 Sep;83:122-133
pubmed: 28701277
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):687-702
pubmed: 25488778
J Bone Miner Res. 2012 Jun;27(6):1357-67
pubmed: 22407806
Immunity. 2019 Feb 19;50(2):432-445.e7
pubmed: 30683619
Lancet. 2016 Oct 22;388(10055):2039-2052
pubmed: 27112094
Nature. 2019 Jun;570(7760):246-251
pubmed: 31142839

Auteurs

Jasna Friščić (J)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Kerstin Dürholz (K)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Xi Chen (X)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Cecilia Engdahl (C)

Department of Rheumatology and Inflammation Research, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.

Lisa Möller (L)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Georg Schett (G)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Mario M Zaiss (MM)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Markus H Hoffmann (MH)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum fuer Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH